產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
- 400-999-210024小時(shí)服務(wù)熱線
人主動(dòng)脈平滑肌細(xì)胞
貨號(hào):CP-H081
規(guī)格:5×10?Cells/T25培養(yǎng)瓶
價(jià)格: ¥8880
產(chǎn)品概述
人主動(dòng)脈平滑肌細(xì)胞
Cat NO.: CP-H081
1.產(chǎn)品名稱:人主動(dòng)脈平滑肌細(xì)胞
2.組織來源:主動(dòng)脈組織
3.產(chǎn)品規(guī)格:5×105cells/T25細(xì)胞培養(yǎng)瓶
4.細(xì)胞簡介:
人主動(dòng)脈平滑肌細(xì)胞分離自主動(dòng)脈組織;主動(dòng)脈是體循環(huán)的動(dòng)脈主干。其運(yùn)行路徑為:升主動(dòng)脈起于左心室,至右側(cè)第2胸肋關(guān)節(jié)高度移行為主動(dòng)脈弓,弓行向左后至第4胸椎體下緣移行為降主動(dòng)脈;在第12胸椎體高度穿膈的主動(dòng)脈裂孔移行為腹主動(dòng)脈,以上為胸主動(dòng)脈,至第4腰椎體下緣分為左、右髂總動(dòng)脈;髂總動(dòng)脈在骶髂關(guān)節(jié)高度分為髂內(nèi)、外動(dòng)脈。主動(dòng)脈平滑肌細(xì)胞原代分離培養(yǎng)3天后,可見細(xì)胞貼壁伸展,細(xì)胞形態(tài)大小不一,呈梭形、不規(guī)則形、三角形或扇形,核卵圓形、居中;2周后細(xì)胞匯合,多數(shù)細(xì)胞伸展呈長梭形,胞漿豐富,有分枝狀突起,細(xì)胞平行排列成單層或部分區(qū)域多層重疊生長,高低起伏;細(xì)胞密度低時(shí),常交織成網(wǎng)狀;密度高時(shí),則排列為旋渦狀或柵欄狀。傳代后細(xì)胞生長較快,4-6天即可匯合,并保持上述形態(tài)學(xué)特征和生長特點(diǎn)。主動(dòng)脈平滑肌細(xì)胞在心血管疾病發(fā)生、發(fā)展中具有重要作用,以主動(dòng)脈平滑肌細(xì)胞為實(shí)驗(yàn)研究對(duì)象,探討心血管疾病相關(guān)發(fā)病機(jī)制是目前研究的熱點(diǎn);體外培養(yǎng)的主動(dòng)脈平滑肌細(xì)胞對(duì)于研究其生理功能、藥物作用以及各種致病因素作用下的病理生理改變具重要意義。
5.方法簡介:
普諾賽實(shí)驗(yàn)室分離的人主動(dòng)脈平滑肌細(xì)胞采用胰蛋白酶 - 膠原酶聯(lián)合消化法結(jié)合差速貼壁法制備而來,細(xì)胞總量約為5×10?cells/瓶。
6.質(zhì)量檢測:
普諾賽實(shí)驗(yàn)室分離的人主動(dòng)脈平滑肌細(xì)胞經(jīng)α-SMA免疫熒光鑒定,純度可達(dá)90%以上,且不含有HIV-1、HBV、HCV、支原體、細(xì)菌、酵母和真菌等。
7.培養(yǎng)信息:
包被條件 | |
培養(yǎng)基 | 含F(xiàn)BS、生長添加劑、Penicillin、Streptomycin等 |
產(chǎn)品貨號(hào) | CM-H081 |
換液頻率 | 每2-3天換液一次 |
生長特性 | 貼壁 |
細(xì)胞形態(tài) | 成纖維細(xì)胞樣 |
傳代特性 | 可傳5代左右;3代以內(nèi)狀態(tài)最佳 |
消化液 | 0.25%胰蛋白酶 |
培養(yǎng)條件 | 氣相:空氣,95%;CO2,5% |
人主動(dòng)脈平滑肌細(xì)胞體外培養(yǎng)周期有限;建議使用普諾賽配套的專用生長培養(yǎng)基及正確的操作方法來培養(yǎng),以此保證該細(xì)胞的最佳培養(yǎng)狀態(tài)。
產(chǎn)品手冊
參考文獻(xiàn)
-
Targeted Delivery of Mesenchymal Stem Cell-Derived Bioinspired Exosome-Mimetic Nanovesicles with Platelet Membrane Fusion for Atherosclerotic Treatment(2024/03/13)
作者:Yu Jiang, Miao Yu, Zhifeng Song
期刊:International Journal of Nanomedicine
影響因子 :8.000
引用產(chǎn)品:CP-H081
-
Glucagon-like peptide-1 receptor agonist exendin 4 ameliorates diabetes-associated vascular calcification by regulating mitophagy through the AMPK signaling pathway(2024/05/08)
作者:Kui Chen, Haojie Jin, Ziheng Wu
期刊:MOLECULAR MEDICINE
DOI:10.1186/s10020-024-00817-8
影響因子 :5.700
引用產(chǎn)品:CP-H081
-
Alginate oligosaccharide alleviates vascular aging by upregulating glutathione peroxidase 7(2024/01/10)
作者:Shan Wang, Yao Yu, Jia Liu
期刊:JOURNAL OF NUTRITIONAL BIOCHEMISTRY
DOI:10.1016/j.jnutbio.2024.109578
影響因子 :5.600
引用產(chǎn)品:CP-H081
-
Ameliorative Effect of Coenzyme Q10 on Phenotypic Transformation in Human Smooth Muscle Cells with FBN1 Knockdown(2024/02/25)
作者:Xu Zhang, Zhengyang Zhang, Sitong Wan
期刊:INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
影響因子 :5.600
引用產(chǎn)品:CP-H081
-
Dynamin-related protein 1 mediates the therapeutic effect of isoliquiritigenin in diabetic intimal hyperplasia via regulation of mitochondrial fission(2024/05/15)
作者:Baofu Zhang, Ziheng Wu, Kui Chen
期刊:HYPERTENSION RESEARCH
DOI:10.1038/s41440-024-01681-z
影響因子 :5.400
引用產(chǎn)品:CP-H081
-
GALNT3 protects against vascular calcification by reducing oxidative stress and apoptosis of smooth muscle cells(2022/12/05)
作者:Yikai Wang, Shijie Li, Lulu Zhou
期刊:EUROPEAN JOURNAL OF PHARMACOLOGY
DOI:10.1016/j.ejphar.2022.175447
影響因子 :5.000
引用產(chǎn)品:CP-H081
-
GALNT3 protects against phosphate-induced calcification in vascular smooth muscle cells by enhancing active FGF23 and inhibiting the wnt/β-catenin signaling pathway(2022/09/23)
作者:Liwei Guo, Yikai Wang, Shijie Li
期刊:CELLULAR SIGNALLING
DOI:10.1016/j.cellsig.2022.110477
影響因子 :4.800
引用產(chǎn)品:CP-H081
-
HIF-1α Contributes to Hypoxia-induced VSMC Proliferation and Migration by Regulating Autophagy in Type A Aortic Dissection(2023/10/02)
作者:Ben Huang, Nan Chen, Zhenhang Chen
期刊:Advanced Biology
影響因子 :3.700
引用產(chǎn)品:CP-H081
-
Cytoprotective effects of C1s enzyme in macrophages in atherosclerosis mediated through the LRP5 and Wnt/β-catenin pathway(2024/01/12)
作者:Dong Yuan, Zhipeng Zheng, Cheng Shen
期刊:MOLECULAR IMMUNOLOGY
DOI:10.1016/j.molimm.2024.01.002
影響因子 :3.600
引用產(chǎn)品:CP-H081
-
Silencing a disintegrin and metalloproteinase?33 attenuates the proliferation of vascular smooth muscle cells via PI3K/AKT pathway: Implications in the pathogenesis of airway vascular remodeling(2021/5/9)
作者:Fang Yan, Yanyan Hao, Xinji Gong
期刊:Molecular Medicine Reports
影響因子 :3.400
-
Combined effects of hyperphosphatemia and hyperglycemia on the calcification of cultured human aortic smooth muscle cells(2018/11/28)
作者:Ping Wang, Ping Zhou, Wangshan Chen
期刊:Experimental and Therapeutic Medicine
影響因子 :2.700
引用產(chǎn)品:CP-H081
-
ADAM33 Silencing Inhibits Vascular Smooth Muscle Cell Migration and Regulates Cytokine Secretion in Airway Vascular Remodeling via the PI3K/AKT/mTOR Pathway(2022/08/31)
作者:Fang Yan, Xin Hu, Long He
期刊:Canadian Respiratory Journal
影響因子 :2.200
-
Hypoxia-Inducible Factor-1α Regulates High Phosphate-Induced Vascular Calcification via Type III Sodium-Dependent Phosphate Cotransporter 1(2024/03/26)
作者:Chengkun Guo, Zhengli Quan, Jingjing Ke
期刊:Cardiology Research and Practice
影響因子 :2.100
引用產(chǎn)品:CP-H081
-
Phosphonoformic acid reduces hyperphosphatemia-induced vascular calcification via Pit-1(2024/01/05)
作者:Hualong Zang, Yang Liu, Qiuping Teng
期刊:JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
影響因子 :1.600
引用產(chǎn)品:CP-H081
FAQs
Q:{{item.question}}
A:{{item.answer}}
產(chǎn)品資料
識(shí)別碼示意圖